Laughing gas does not increase heart attacks.
Nitrous
oxide — best known as laughing gas — is one of the world’s oldest and most
widely used anesthetics.
Despite
its popularity, however, experts have questioned its impact on the risk of a
heart attack during surgery or soon afterward.
But
those fears are unfounded, a new study indicates.
The
findings by researchers at Washington University School of Medicine in St.
Louis will appear in the July issue of the journal Anesthesiology.
“It’s
been known for quite a while that laughing gas inactivates vitamin B12 and, by
doing so, increases blood levels of the amino acid homocysteine,” said lead
author Peter Nagele, MD, assistant professor of anesthesiology and genetics.
“That was thought to raise the risk of a heart attack during and after surgery,
but we found no evidence of that in this study.”
Nitrous
oxide normally is used as an adjunct during general anesthesia because by
itself the drug isn’t strong enough to keep patients unconscious during
surgical procedures. The drug’s influence on B vitamins and homocysteine is
unrelated to its anesthetic effects.
Nagele
and his colleagues followed 500 surgery patients with coronary artery disease,
heart failure or other health problems that could contribute to a heart attack.
All subjects in the study had noncardiac surgery and received nitrous oxide
anesthesia.
The
patients were divided into two groups. Half received intravenous vitamin B12
and folic acid to help prevent homocysteine levels from rising during surgery.
The others did not get the intravenous B vitamins.
“There
were no differences between the groups with regard to heart attack risk,”
Nagele said. “The B vitamins kept homocysteine levels from rising, but that
didn’t influence heart attack risk.”
To
detect heart attacks during and after surgery, the researchers monitored a
marker of heart damage, cardiac troponin I, for 72 hours. A rise in troponin levels
indicates damage to the heart. But they found no link between patients’
homocysteine and troponin levels.
The
study also looked at gene variations that naturally lead to elevated
homocysteine. Individuals with common variants in the MTHFR gene already make
excess homocysteine. If people with those variants then get nitrous oxide
anesthesia, their levels can climb even higher.
But
only 3.1 % of patients with the high-risk genetic variants had heart attacks
during or after surgery, compared with 4.7 % of the patients who didn’t have
the risky variants. Neither the gene variation nor treatment with B vitamins
had an effect on troponin levels following surgery.
“People
who had the gene variant did, indeed, develop very high levels of homocysteine
in response to nitrous oxide,” Nagele said.
So
the question is whether those patients would be at a higher risk for heart
attack, and that answer is no.”
Nagele
P, Brown F, Francis A, Scott MG, Gage BF, Miller JP, and the VINO study team.
Influence of nitrous oxide anesthesia, B-vitamins, and MTHFR gene polymorphisms
on perioperative cardiac events: the vitamins in nitrous oxide (VINO)
randomized trial. Anesthesiology, 119: pp. 19-28, July 2013
No comments:
Post a Comment